node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
flp-1 | flp-10 | F23B2.5a.1 | T06C10.4.1 | FMRFamide-like neuropeptides 1; Together with flp-18, plays a homeostatic role by acting on the GABAergic neural transmission at neuromuscular junctions to prevent overexcitation of the locomotor circuit. DPNFLRF-amide: Inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | FMRFamide-like peptide 10. | 0.697 |
flp-1 | flp-12 | F23B2.5a.1 | C05E11.8a.1 | FMRFamide-like neuropeptides 1; Together with flp-18, plays a homeostatic role by acting on the GABAergic neural transmission at neuromuscular junctions to prevent overexcitation of the locomotor circuit. DPNFLRF-amide: Inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | FMRFamide-like peptide 12. | 0.928 |
flp-1 | flp-13 | F23B2.5a.1 | F33D4.3.1 | FMRFamide-like neuropeptides 1; Together with flp-18, plays a homeostatic role by acting on the GABAergic neural transmission at neuromuscular junctions to prevent overexcitation of the locomotor circuit. DPNFLRF-amide: Inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | FMRFamide-like neuropeptides 13; FMRFamides and FMRFamide-like peptides are neuropeptides. APEASPFIRF-amide: Inhibits muscle tension in somatic muscle. Potent inhibitor of the activity of the dissected pharyngeal myogenic muscle system. [SPSAVPLIRF-amide]: Acts as a ligand for the npr-22 receptor in vitro. [ASSAPLIRF-amide]: Acts as a ligand for the npr-22 receptor in vitro; Belongs to the FARP (FMRFamide related peptide) family. | 0.820 |
flp-1 | flp-19 | F23B2.5a.1 | M79.4.1 | FMRFamide-like neuropeptides 1; Together with flp-18, plays a homeostatic role by acting on the GABAergic neural transmission at neuromuscular junctions to prevent overexcitation of the locomotor circuit. DPNFLRF-amide: Inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | FMRFamide-like neuropeptides 19; FMRFamides and FMRFamide-like peptides are neuropeptides. WANQVRF-amide inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | 0.805 |
flp-1 | flp-20 | F23B2.5a.1 | E01H11.3.1 | FMRFamide-like neuropeptides 1; Together with flp-18, plays a homeostatic role by acting on the GABAergic neural transmission at neuromuscular junctions to prevent overexcitation of the locomotor circuit. DPNFLRF-amide: Inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | FMRF-Like Peptide. | 0.713 |
flp-1 | flp-5 | F23B2.5a.1 | C03G5.7.1 | FMRFamide-like neuropeptides 1; Together with flp-18, plays a homeostatic role by acting on the GABAergic neural transmission at neuromuscular junctions to prevent overexcitation of the locomotor circuit. DPNFLRF-amide: Inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | FMRFamide-like neuropeptides 5; FMRFamides and FMRFamide-like peptides are neuropeptides. GAKFIRF-amide has an excitatory effect on dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | 0.809 |
flp-1 | flp-6 | F23B2.5a.1 | F07D3.2.1 | FMRFamide-like neuropeptides 1; Together with flp-18, plays a homeostatic role by acting on the GABAergic neural transmission at neuromuscular junctions to prevent overexcitation of the locomotor circuit. DPNFLRF-amide: Inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | FMRFamide-like neuropeptides 6; FMRFamides and FMRFamide-like peptides are neuropeptides. KSAYMRF-amide has an excitatory effect on dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | 0.831 |
flp-1 | flp-8 | F23B2.5a.1 | F31F6.4a.1 | FMRFamide-like neuropeptides 1; Together with flp-18, plays a homeostatic role by acting on the GABAergic neural transmission at neuromuscular junctions to prevent overexcitation of the locomotor circuit. DPNFLRF-amide: Inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | FMRFamide-like peptide 8. | 0.837 |
flp-1 | flp-9 | F23B2.5a.1 | C36H8.3.1 | FMRFamide-like neuropeptides 1; Together with flp-18, plays a homeostatic role by acting on the GABAergic neural transmission at neuromuscular junctions to prevent overexcitation of the locomotor circuit. DPNFLRF-amide: Inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | FMRFamide-like neuropeptides 9; FMRFamides and FMRFamide-like peptides are neuropeptides. Belongs to the FARP (FMRFamide related peptide) family. | 0.881 |
flp-10 | flp-1 | T06C10.4.1 | F23B2.5a.1 | FMRFamide-like peptide 10. | FMRFamide-like neuropeptides 1; Together with flp-18, plays a homeostatic role by acting on the GABAergic neural transmission at neuromuscular junctions to prevent overexcitation of the locomotor circuit. DPNFLRF-amide: Inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | 0.697 |
flp-10 | flp-12 | T06C10.4.1 | C05E11.8a.1 | FMRFamide-like peptide 10. | FMRFamide-like peptide 12. | 0.810 |
flp-10 | flp-13 | T06C10.4.1 | F33D4.3.1 | FMRFamide-like peptide 10. | FMRFamide-like neuropeptides 13; FMRFamides and FMRFamide-like peptides are neuropeptides. APEASPFIRF-amide: Inhibits muscle tension in somatic muscle. Potent inhibitor of the activity of the dissected pharyngeal myogenic muscle system. [SPSAVPLIRF-amide]: Acts as a ligand for the npr-22 receptor in vitro. [ASSAPLIRF-amide]: Acts as a ligand for the npr-22 receptor in vitro; Belongs to the FARP (FMRFamide related peptide) family. | 0.693 |
flp-10 | flp-19 | T06C10.4.1 | M79.4.1 | FMRFamide-like peptide 10. | FMRFamide-like neuropeptides 19; FMRFamides and FMRFamide-like peptides are neuropeptides. WANQVRF-amide inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | 0.699 |
flp-10 | flp-20 | T06C10.4.1 | E01H11.3.1 | FMRFamide-like peptide 10. | FMRF-Like Peptide. | 0.809 |
flp-10 | flp-5 | T06C10.4.1 | C03G5.7.1 | FMRFamide-like peptide 10. | FMRFamide-like neuropeptides 5; FMRFamides and FMRFamide-like peptides are neuropeptides. GAKFIRF-amide has an excitatory effect on dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | 0.690 |
flp-10 | flp-6 | T06C10.4.1 | F07D3.2.1 | FMRFamide-like peptide 10. | FMRFamide-like neuropeptides 6; FMRFamides and FMRFamide-like peptides are neuropeptides. KSAYMRF-amide has an excitatory effect on dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | 0.802 |
flp-10 | flp-8 | T06C10.4.1 | F31F6.4a.1 | FMRFamide-like peptide 10. | FMRFamide-like peptide 8. | 0.814 |
flp-10 | flp-9 | T06C10.4.1 | C36H8.3.1 | FMRFamide-like peptide 10. | FMRFamide-like neuropeptides 9; FMRFamides and FMRFamide-like peptides are neuropeptides. Belongs to the FARP (FMRFamide related peptide) family. | 0.760 |
flp-12 | flp-1 | C05E11.8a.1 | F23B2.5a.1 | FMRFamide-like peptide 12. | FMRFamide-like neuropeptides 1; Together with flp-18, plays a homeostatic role by acting on the GABAergic neural transmission at neuromuscular junctions to prevent overexcitation of the locomotor circuit. DPNFLRF-amide: Inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | 0.928 |
flp-12 | flp-10 | C05E11.8a.1 | T06C10.4.1 | FMRFamide-like peptide 12. | FMRFamide-like peptide 10. | 0.810 |